Distinct activation pathways confer cyclin-binding specificity on Cdk1 and Cdk2 in human cells

Area of Science:

• Cell Biology
• Molecular Biology
• Biochemistry

Background:

• Cyclin-dependent kinases (CDKs) are crucial regulators of the cell cycle in metazoans.
• CDKs bind to regulatory cyclin partners to control cell division progression.
• Understanding CDK-cyclin specificity is key to comprehending cell cycle control.

Purpose of the Study:

• To investigate the molecular basis of CDK-cyclin binding preferences in human cells.
• To elucidate the distinct activation mechanisms of CDK1 and CDK2.
• To determine the role of CDK-activating kinase (CAK) in enforcing CDK-cyclin specificity.

Main Methods:

• Chemical genetics to dissect CDK activation pathways.
• In vitro biochemical assays using cell extracts.
• In vivo experiments involving CDK7 inhibition.

Main Results:

• Cyclin A preferentially binds Cdk2 over Cdk1, even when Cdk1 is more abundant.
• Cdk1 and Cdk2 activation by CDK-activating kinase (CAK) Cdk7 occurs via kinetically distinct mechanisms.
• Modulating CAK activity in vitro and in vivo alters CDK-cyclin binding specificity, demonstrating the importance of activation order.

Conclusions:

• Differential ordering of common activation steps, catalyzed by Cdk7, promotes CDK-cyclin specificity.
• The timing and mechanism of CDK activation, rather than just protein levels, dictate cyclin binding.
• This regulatory mechanism ensures fidelity in cell cycle progression.